General presentation of Biogen
Let's now move on to another important part of your analysis of Biogen's share price, which consists of a good knowledge of the company and its various activities. Indeed, it is through this knowledge and an understanding of the sources of income of this group that you will be most likely to anticipate the growth issues of this company.
The Biogen Inc. group is an American company operating in the pharmaceutical sector. More specifically, this company is currently one of the leaders in the design, production and sale of therapeutic products worldwide.
In order to better understand the Biogen group's activities, they can be broken down into several divisions according to the share of turnover they generate :
- Drug sales represent the bulk of Biogen's business and alone generate 79.2% of the company's sales. These include medicines for the treatment of multiple sclerosis, chronic adult psoriasis, rheumatoid arthritis, cancers and other diseases.
- The Biogen group also generates nearly 15.9% of its revenues through the collection of royalties from the use of patents it has filed.
- Finally, the remaining 4.9% of the company's turnover, i.e. 4.9%, comes from other activities and in particular a large part of the income from various partnership agreements.
Photo credits: ©diy13/123RF.COM